Fibronectin inhibition restores myelination in endothelial TNFR2–dependent nonremitting experimental autoimmune encephalomyelitis
Proceedings of the National Academy of Sciences · 2026
DOI: 10.1073/pnas.2616799123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2026. Verfasst von Aikaterini Nanou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Bioinnovation, Biomedical Sciences Research Center "Alexander Fleming", Athens 16672, Greece. Hauptthemen laut MEDLINE: Encephalomyelitis, Autoimmune, Experimental, Fibronectins, Receptors, Tumor Necrosis Factor, Type II, Myelin Sheath. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Hellenic Foundation for Research and Innovation (HFRI), EC | Horizon Europe | Excellent Science | HORIZON EUROPE European Research Council (ERC), EC | European Regional Development Fund (ERDF).
Abstract (Originalsprache)
In multiple sclerosis (MS), spontaneous remyelination occurs in early disease; however, this process becomes inefficient over time, resulting in sustained neurodegeneration and clinical deterioration. It is known that global tumor necrosis factor receptor 2 (TNFR2) deletion in experimental autoimmune encephalomyelitis (EAE), the murine MS model, causes a severe nonremitting disease; however, the underlying mechanism is poorly understood. Here, through bulk and single nucleus RNA sequencing, we identify endothelial TNFR2 deletion as the driver of nonremitting disease, as it is sufficient to drive a severe nonremitting phenotype that closely mirrors global TNFR2 loss. Remyelination failure upon endothelial cell–specific TNFR2 ablation was also detected at the Cuprizone model of remyelination confirming its dominant role in central nervous system (CNS) repair. Notably, this effect was independent of immune cell influx or vascular permeability changes but associated with fibronectin overexpression and accumulation in demyelinating lesions. Fibronectin accumulation led to the sequestering of oligodendrocyte progenitor cells (OPCs) at the demyelination areas and prevented myelin repair. Therapeutically, systemic fibronectin inhibition restored regeneration and clinical remission, as well as prevented OPC accumulation at lesions, providing strong preclinical evidence for fibronectin-targeting therapies in MS and other demyelinating disorders. These findings establish endothelial cells as key regulators of the parenchymal environment permissive to remyelination and open avenues for MS treatment strategies focused on vascular-driven CNS regeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Bioinnovation, Biomedical Sciences Research Center "Alexander Fleming", Athens 16672, Greece.
- Center of New Biotechnologies and Precision Medicine, School of Medicine, National and Kapodistrian University of Athens, Athens 11527, Greece.
- Department of Physiology, Medical School, National and Kapodistrian University of Athens, Athens 11527, Greece.
ORCID-Profile: Aikaterini Nanou, Konstantinos Apostolou-Karampelis, Maria C Denis, George Kollias
Förderung
- Hellenic Foundation for Research and Innovation (HFRI)
- EC | Horizon Europe | Excellent Science | HORIZON EUROPE European Research Council (ERC)
- EC | European Regional Development Fund (ERDF)
Zitieren
APA
Nanou, A., Apostolou-Karampelis, K., Triantafyllidou, V., Sakkou, M., Roumelioti, F., Denis, M. C., & Kollias, G. (2026). Fibronectin inhibition restores myelination in endothelial TNFR2–dependent nonremitting experimental autoimmune encephalomyelitis. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2616799123
Vancouver
Nanou A, Apostolou-Karampelis K, Triantafyllidou V, Sakkou M, Roumelioti F, Denis MC, et al. Fibronectin inhibition restores myelination in endothelial TNFR2–dependent nonremitting experimental autoimmune encephalomyelitis. Proceedings of the National Academy of Sciences. 2026. doi:10.1073/pnas.2616799123
BibTeX
@article{Nanou2026,
author = {Nanou, Aikaterini and Apostolou-Karampelis, Konstantinos and Triantafyllidou, Vasiliki and Sakkou, Maria and Roumelioti, Fani and Denis, Maria C and Kollias, George},
title = {Fibronectin inhibition restores myelination in endothelial TNFR2–dependent nonremitting experimental autoimmune encephalomyelitis},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
doi = {10.1073/pnas.2616799123}
}
EUVIMED